tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate CAS 571188-59-5 Kemurnian >99,0% (HPLC) Palbociclib Intermediate Factory
Ruifu Chemical Supply Palbociclib Related Intermediates:
Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butil 4-(6-Nitropyridin-3-yl)piperazin-1-Karboksilat CAS 571189-16-7
tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pirimidin-7(8H)-siji CAS 1016636-76-2
2-Chloro-8-Cyclopentyl-5-Methyl-8H-Pyrido[2,3-d]pirimidin-7-siji CAS 1013916-37-4
Jeneng Kimia | tert-Butil 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate |
sinonim | 4-(6-Amino-3-Pyridyl)-1-Boc-Piperazine;1-Boc-4-(6-Amino-3-Pyridyl) piperazine;4-(6-Amino-3-piridil)piperazin-1-Asam Karboksilat tert-Butil Ester;1-tert-Butoxycarbonyl-4-(6-Amino-3-pyridyl) piperazine;Palbociclib Impurity 10;Palbociclib Intermediate 1;Otava-Bb 1207229 |
Nomer CAS | 571188-59-5 |
Nomer CAT | RF-PI1848 |
Status Simpenan | Ing Simpenan, Skala Produksi Nganti Ton |
Formula Molekul | C14H22N4O2 |
Bobot Molekul | 278.35 |
Titik Lebur | 131,0 kanggo 135,0 ℃ |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Bubuk Putih nganti Kuning Cahya |
Identifikasi dening HPLC | Wektu retensi puncak utama ing HPLC kudu cocog karo standar referensi |
Kemurnian / Metode Analisis | > 99,0% (HPLC) |
Mundhut ing Pangatusan | <0,50% |
Sisa ing Ignition | <0,20% |
Total Impurities | <1.00% |
Test Standar | Standar Perusahaan |
Panggunaan | Penengah Palbociclib (CAS: 571190-30-2) |
Paket: Botol, tas Aluminium foil, 25kg / Karton Drum, utawa miturut kabutuhan pelanggan
Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan
tert-Butyl 4-(6-Amino-3-pyridyl)piperazine-1-carboxylate (CAS: 571188-59-5) digunakake minangka penengah pharmaceutical.Iki minangka perantara saka Palbociclib (CAS: 571190-30-2).Palbociclib minangka obat kanggo perawatan kanker payudara ER-positif lan HER2-negatif sing dikembangake.Palbociclib minangka inhibitor selektif saka kinase sing gumantung karo cyclin CDK4 lan CDK6.